Skip to content
10-Q

Quarterly Report

KYMERA THERAPEUTICS, INC. KYMR

0000950170-25-106229

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 71.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 80.45M sh
Shares Diluted Q2 2025 · Jun 30, 2025 80.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 73.06M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.91M sh
Capex Q2 2025 · Jun 30, 2025 $1.16M
Capex Q2 2025 · Jun 30, 2024 $12.09M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$139.03M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$82.53M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $335.82M
Cash And Equivalents Q2 2025 · Mar 31, 2025 $335.82M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $120.26M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $67.61M
Stockholders Equity Q2 2025 · Jun 30, 2025 $971.48M
Stockholders Equity Q2 2025 · Mar 31, 2025 $786.23M
Stockholders Equity Q2 2025 · Dec 31, 2024 $835.62M
Stockholders Equity Q2 2025 · Jun 30, 2024 $684.92M
Stockholders Equity Q2 2025 · Mar 31, 2024 $711.2M
Stockholders Equity Q2 2025 · Dec 31, 2023 $394.97M
Current Liabilities Q2 2025 · Jun 30, 2025 $87.54M
Current Liabilities Q2 2025 · Dec 31, 2024 $67.77M
Total Liabilities Q2 2025 · Jun 30, 2025 $159.59M
Total Liabilities Q2 2025 · Dec 31, 2024 $142.42M
Current Assets Q2 2025 · Jun 30, 2025 $728.33M
Current Assets Q2 2025 · Dec 31, 2024 $510.27M
Total Assets Q2 2025 · Jun 30, 2025 $1.13B
Total Assets Q2 2025 · Dec 31, 2024 $978.04M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.95
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.77
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.58
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.26
Eps Basic Q2 2025 · Jun 30, 2025 −$0.95
Eps Basic Q2 2025 · Jun 30, 2025 −$1.77
Eps Basic Q2 2025 · Jun 30, 2024 −$0.58
Eps Basic Q2 2025 · Jun 30, 2024 −$1.26
Sga Expense Q2 2025 · Jun 30, 2025 $17.65M
Sga Expense Q2 2025 · Jun 30, 2025 $33.92M
Sga Expense Q2 2025 · Jun 30, 2024 $17.37M
Sga Expense Q2 2025 · Jun 30, 2024 $31.75M
Rd Expense Q2 2025 · Jun 30, 2025 $78.39M
Rd Expense Q2 2025 · Jun 30, 2025 $158.64M
Rd Expense Q2 2025 · Jun 30, 2024 $59.2M
Rd Expense Q2 2025 · Jun 30, 2024 $108.02M
Net Income Q2 2025 · Jun 30, 2025 −$76.61M
Net Income Q2 2025 · Jun 30, 2025 −$142.2M
Net Income Q2 2025 · Jun 30, 2024 −$42.06M
Net Income Q2 2025 · Jun 30, 2024 −$90.62M
Operating Income Q2 2025 · Jun 30, 2025 −$84.56M
Operating Income Q2 2025 · Jun 30, 2025 −$158.98M
Operating Income Q2 2025 · Jun 30, 2024 −$50.93M
Operating Income Q2 2025 · Jun 30, 2024 −$108.76M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11.48M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $33.58M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $25.65M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $35.94M
Revenue Q2 2025 · Jun 30, 2025 $11.48M
Revenue Q2 2025 · Jun 30, 2025 $33.58M
Revenue Q2 2025 · Jun 30, 2024 $25.65M
Revenue Q2 2025 · Jun 30, 2024 $35.94M